Chronic obstructive pulmonary disease – importance of active case finding and consideration of comorbidities

Frank Rassouli

doi:10.4414/smw.2017.14466

Viewpoint

Vol. 147 No. 3132 (2017)

Chronic obstructive pulmonary disease – importance of active case finding and consideration of comorbidities

Frank Rassouli

DOI: https://doi.org/10.4414/smw.2017.14466
Cite this as:: Swiss Med Wkly. 2017;147:w14466
Published: 03.08.2017

References

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2017 report). Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–85.https://doi.org/10.1183/09031936.00128008
Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–12.https://doi.org/10.1183/09031936.00114307
Houben-Wilke S, Jörres RA, Bals R, Franssen FM, Gläser S, Holle R, et al. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study. Am J Respir Crit Care Med. 2017;195(2):189–97.https://doi.org/10.1164/rccm.201602-0354OC
Tschopp J, Dumont P, Hayoz D. True prevalence of COPD and its association with peripheral arterial disease in the internal medicine ward of a tertiary care hospital. Swiss Med Wkly. 2017;147:w14460. https://smw.ch/en/article/doi/smw.2017.14460/.

Publication image

How to Cite

1.

Rassouli F. Chronic obstructive pulmonary disease – importance of active case finding and consideration of comorbidities. Swiss Med Wkly [Internet]. 2017 Aug. 3 [cited 2024 Apr. 19];147(3132):w14466. Available from: https://smw.ch/index.php/smw/article/view/2337

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Martin Brutsche, Frank Rassouli, Harald Gallion, Sanjay Kalra, Veronique L Roger, Florent Baty, Diagnostic diversity – an indicator of institutional and regional healthcare quality , Swiss Medical Weekly: Vol. 148 No. 4950 (2018)

[1] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2017 report). Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/

[2] Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–85.https://doi.org/10.1183/09031936.00128008

[3] Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–12.https://doi.org/10.1183/09031936.00114307

[4] Houben-Wilke S, Jörres RA, Bals R, Franssen FM, Gläser S, Holle R, et al. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study. Am J Respir Crit Care Med. 2017;195(2):189–97.https://doi.org/10.1164/rccm.201602-0354OC

[5] Tschopp J, Dumont P, Hayoz D. True prevalence of COPD and its association with peripheral arterial disease in the internal medicine ward of a tertiary care hospital. Swiss Med Wkly. 2017;147:w14460. https://smw.ch/en/article/doi/smw.2017.14460/.